EUVIMEDEUVIMED entdecken
Crossref

Modulation of CD8+T cells, NK cells and Th1cytokines by metabolic milieu in decline of HBV-viremia in pregnant women treated with tenofovir-disoproxil from second trimester of pregnancy

Prabhjyoti Pahwa, Ashish Kumar Vyas, Jayesh Kumar Sevak, Ravinder Singh, Jaswinder Singh Maras, Sharda Patra, Shiv K Sarin, Nirupama Trehanpati

Journal of Reproductive Immunology · 2024

DOI: 10.1016/j.jri.2024.104208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2024. Verfasst von Prabhjyoti Pahwa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Hepatitis B virus, Infectious Disease Transmission, Vertical, Pregnancy Complications, Infectious, Viremia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High HBV DNA levels predispose to mother to child transmission (MTCT) of HBV. Early nucleotide analogue (NA) therapy can reduce HBV DNA and minimize MTCT. We analysed immune-metabolic profile in pregnant mothers who received NA from 2nd trimester compared with untreated mothers. In 2nd trimester, there was no difference in immune profiles between Gr.1 and Gr.2 but high viral load women had downregulated pyruvate, NAD+ metabolism but in 3rd trimester, Gr.1 had significant reduction in HBV-DNA, upregulated pyruvate and NAD with increased IFN-2αA, CD8Tcells, NK cells and decreased Tregs, IL15, IL18, IL29, TGFβ3 compared to Gr.2. In Gr.1, three eAg-ve women showed undetectable DNA and HBsAg. At delivery, Gr.1 showed no MTCT, with undetectable HBV DNA, HBsAg, high CD8 and NK cells in two women. We conclude, that starting NA from second trimester, reduces HBV load and MTCT, modulates NAD, induces immunity and suggest use of NA in early gestation in future trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousViremiaHepatitis BChildFemaleHumansPregnancyCD8-Positive T-LymphocytesDNA, ViralHepatitis B Surface AntigensKiller Cells, NaturalNADPregnancy Trimester, SecondPyruvatesTenofovir

Stichwörter der Autor:innen

Energy-metabolismHepatitis BPregnancyTenofovir-disoproxil

Substanzen

DNA, ViralHepatitis B Surface AntigensNADPyruvatesTenofovir

Autor:innen und Institutionen

  • Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Department of Obstetrics and Gynaecology, Lady Harding Medical College, New Delhi, India.
  • Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India. Electronic address: shivsarin@gmail.com.
  • Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India. Electronic address: trehanpati@ilbs.in.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Pahwa, P., Vyas, A. K., Sevak, J. K., Singh, R., Maras, J. S., Patra, S., Sarin, S. K., & Trehanpati, N. (2024). Modulation of CD8+T cells, NK cells and Th1cytokines by metabolic milieu in decline of HBV-viremia in pregnant women treated with tenofovir-disoproxil from second trimester of pregnancy. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2024.104208

Vancouver

Pahwa P, Vyas AK, Sevak JK, Singh R, Maras JS, Patra S, et al. Modulation of CD8+T cells, NK cells and Th1cytokines by metabolic milieu in decline of HBV-viremia in pregnant women treated with tenofovir-disoproxil from second trimester of pregnancy. Journal of Reproductive Immunology. 2024. doi:10.1016/j.jri.2024.104208

BibTeX
@article{Pahwa2024,
  author = {Pahwa, Prabhjyoti and Vyas, Ashish Kumar and Sevak, Jayesh Kumar and Singh, Ravinder and Maras, Jaswinder Singh and Patra, Sharda and Sarin, Shiv K and Trehanpati, Nirupama},
  title = {Modulation of CD8+T cells, NK cells and Th1cytokines by metabolic milieu in decline of HBV-viremia in pregnant women treated with tenofovir-disoproxil from second trimester of pregnancy},
  journal = {Journal of Reproductive Immunology},
  year = {2024},
  doi = {10.1016/j.jri.2024.104208}
}
Kostenlos starten →